Crimson Publishers Publish With Us Reprints e-Books Video articles

Abstract

Research in Medical & Engineering Sciences

Medicines Distribution and Financing Alternatives

  • Open or Close Abdeen Mustafa Omer*

    Occupational Health Administration, Ministry of Health, Sudan

    *Corresponding author: Abdeen Mustafa Omer, Occupational Health Administration, Ministry of Health, Sudan, Email: abdeenomer2@yahoo.co.uk

Submission: July 05, 2017; Published: February 22, 2018

DOI: 10.31031/RMES.2018.03.000571

ISSN : 2576-8816
Volume3 Issue5

Abstract

The strategy of price liberalisation and privatisation had been implemented in Sudan over the last decade, and has had a positive result on government deficit. The investment law approved recently has good statements and rules on the above strategy in particular to pharmacy regulations. Under the pressure of the new privatisation policy, the government introduced radical changes in the pharmacy regulations. To improve the effectiveness of the public pharmacy, resources should be switched towards areas of need, reducing inequalities and promoting better health conditions. Medicines are financed either through cost sharing or full private. The role of the private services is significant.

A review of reform of financing medicines in Sudan is given in this study. Also, it highlights the current drug supply system in the public sector, which is currently responsibility of the Central Medical Supplies Public Corporation (CMS). In Sudan, the researchers did not identify any rigorous evaluations or quantitative studies about the impact of drug regulations on the quality of medicines and how to protect public health against counterfeit or low quality medicines, although it is practically possible. However, the regulations must be continually evaluated to ensure the public health is protected against by marketing high quality medicines rather than commercial interests, and the drug companies are held accountable for their conduct.

Keywords: Counterfeits medicines; Drug importers; Quality of medicines; Regulatory authorities

Abbreviation: CMSPO: Central Medical Supplies Public Organisation; CRC: Centre of Regulation and Competition; DAP: Drug Action Programme; DOP: Department of Pharmacy; FGDOP: Federal General Directorate of Pharmacy; FMOH: Federal Ministry of Health; FPPB: Federal Pharmacy and Poison Board; GMP: Good Manufacturing Practice; KS: Khartoum State; MOAR: Ministry of Animal Resources; MOH: Ministry of Health; NGOs: Non Governmental Organizations; NDP: National Drug Policy; RDFs: Revolving Drug Funds; SPSS: Statistical Package for Social Sciences; UK: United Kingdom; USA: United States of America; WHO: World Health Organisation

Get access to the full text of this article